relapsed/refractory mcrc: immunotherapy in msi-high tumors
Published 4 years ago • 317 plays • Length 8:34Download video MP4
Download video MP3
Similar videos
-
6:54
key takeaway 7: role of immunotherapy in msi-high mcrc
-
4:32
immunotherapy regimens in dmmr/msi-high metastatic crc
-
7:32
treatment options in refractory mcrc
-
6:27
immunotherapy in msi-high pancreatic tumors
-
4:00
immunotherapy combinations in msi and mss mcrc
-
6:34
therapeutic agents in relapsed/refractory mcrc
-
9:02
pembrolizumab in msi-h crc tumors
-
5:01
sequencing decisions in relapsed/refractory colorectal cancer
-
9:25
debate: msi high colon cancer - immunotherapy
-
0:35
immunotherapy for msi high colon cancer
-
5:49
immunotherapy and msi status in colorectal cancer
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
5:41
role of immunotherapy in microsatellite-stable r/r mcrc
-
4:26
sequencing of therapy in refractory mcrc
-
6:24
immunotherapy options in refractory crc
-
0:36
discover the link between msi instability and immunotherapy in cancer treatment 🔬🎗️
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
8:04
using i/o in msi-h tumors in mcrc